Evaluation of non-invasive techniques for the diagnosis of pulmonary complications in systemic sclerosis and scleroderma-like overlap syndromes: role of lung ultrasound

Systemic Sclerosis

Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement

Rheumatology (Oxford)

Ross L, Burns AT, La Gerche A, Hansen D, Coghlan JG, Stevens W, Prior D, Pham A, McKelvie P, Bellocchi C, Braun Moscovici Y, Bruni C, Carreira P, Frech T, Hoa S, Hudson M, Hsu V, Hsiu Ling Low A, Matucci-Cerinic M, Medina Fonseca B, Ng SA, Rodriguez Reyna T, Sahhar J, Talaat M, Proudman S, Vacca A, Baron M, Nikpour M, SCTC Cardiac Working Group

doi: 10.1093/rheumatology/keag109

RECOMMENDED

Systemic Sclerosis

Systemic Sclerosis-Associated Interstitial Lung Disease: What We Know and How to Incorporate Guidelines into Clinical Practice

★ 3 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Chest

Esposito AJ, Selvan KC, Richardson C, Khanna D, Bemiss BC, Bernstein EJ, Chung JH, Cox CW, Dematte JE, Denton CP, Distler O, Hinchcliff ME, Smith V, Strek ME, Varga J, Hoffmann-Vold AM, Volkmann ER

doi: 10.1016/j.chest.2025.11.047

Autoimmune Disease

The complex diagnosis of primary heart involvement in systemic sclerosis: red flags to drive the choice of cardiac magnetic resonance

Rheumatology (Oxford)

Veronica B, Palmisano A, Campochiaro C, Vignale D, Bruno E, Peretto G, Sala S, Dagna L, Esposito A, Matucci-Cerinic M, De Luca G

doi: 10.1093/rheumatology/keaf234

Systemic Sclerosis

Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)

J Autoimmun

Barde F, Chevalier K, Decker P, Merin M, Nicolas A, Lescoat A, Deroux A, Koether V, Chatelus E, Coustal C, Maria A, Michaud M, Pugnet G, Murarasu A, Riviere S, Charles P, de Moreuil C, Lodovichetti J, Maillet F, Renaud A, Granel B, Mouthon L, Chaigne B

doi: 10.1016/j.jaut.2025.103492

Systemic Sclerosis

Pregnancy outcomes in women with systemic sclerosis before and/or after diagnosis, and by parity - A Swedish population-based cohort study

Arthritis Rheumatol

Che WI, Annicchiarico L, Andreoli L, Stephansson O, Holmqvist M, Hellgren K

doi: 10.1002/art.43312

Systemic Sclerosis

Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

Arthritis Res Ther

Hiura R, Ayano M, Uchino A, Hiura J, Ueda N, Tanaka A, Yoshizawa S, Kawano S, Sagawa F, Ota SI, Hirata A, Fujimoto S, Nishimura N, Takaki-Kuwahara A, Kimoto Y, Akashi K, Niiro H

doi: 10.1186/s13075-025-03654-0

Systemic Sclerosis

The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)

Ann Rheum Dis

Petelytska L, Tofani L, Velauthapillai A, Dobrota R, Becker MO, Mihai C, Muraru S, Elhai M, Jordan S, Hachulla E, Müller-Ladner U, Siegert E, Allanore Y, Riemekasten G, Bergmann C, Becvar R, Solanki K, Anic B, Szabo I, Stamenkovic B, Distler J, Carreira PE, Cuomo G, Castellví I, Balbir-Gurman A, Airò P, Litinsky I, Saketkoo LA, Bertaccini B, Vonk MC, de Vries-Bouwstra J, Hoffmann-Vold AM, Matucci-Cerinic M, Distler O, Bruni C, EUSTAR collaborators

doi: 10.1016/j.ard.2025.12.008

Rheumatoid Arthritis

The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis

Arthritis Res Ther

Zheng S, Zhou Z, Du G, Chen Q, Chen S, Lin J, Hu S, Zhang W, Zheng K, Zhuang J, Huang M, Ruaro B, Bruni C, Hoffmann-Vold AM, Matucci-Cerinic M, Furst DE, Wang Y

doi: 10.1186/s13075-025-03626-4

Systemic Sclerosis

Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)

Arthritis Res Ther

Liakouli V, Forte G, Ruscitti P, Navarini L, Bellisai F, Caso F, Guggino G, La Barbera L, Rizzo C, Corrado A, Triggianese P, Lo Gullo A, Mandraffino G, Cantarini L, Frediani B, Cipriani P, Cantatore FP, Chimenti MS, Favoino E, Perosa F, Iagnocco A, Giacomelli R, Ciccia F

doi: 10.1186/s13075-025-03619-3

Related content

Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement

Systemic Sclerosis-Associated Interstitial Lung Disease: What We Know and How to Incorporate Guidelines into Clinical Practice

The complex diagnosis of primary heart involvement in systemic sclerosis: red flags to drive the choice of cardiac magnetic resonance

Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)

Pregnancy outcomes in women with systemic sclerosis before and/or after diagnosis, and by parity - A Swedish population-based cohort study

Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)

The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis

Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)